VACCINEX INC
VCNX Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Forecast
Insiders
Institutions
Compensation
Government
Ownership
News
Income
Balance Sheet
Cash Flow
Revenue Breakdown
Recent trades of VCNX by members of U.S. Congress
VCNX Stock Insider Trading Activity
Follow @QuiverQuant for major insider updates
---
Closing Price
Purchase
Sale
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
VCNX Stock Institutional Owners
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
VCNX Derivatives Institutional Owners
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes in VCNX holdings by institutional investors
Quarterly net insider trading by VCNX's directors and management
* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.
- 1M
- 3M
- 6M
- YTD
- 1Y
- 2Y
- 5Y
- MAX
About
Backtest Start Date
Key Metrics
Return (1d)
Return (30d)
Return (1Y)
CAGR (Total)
Max Drawdown
Beta
Alpha
Sharpe Ratio
Win Rate
Average Win
Average Loss
Annual Volatility
Annual Std Dev
Information Ratio
Treynor Ratio
Total Trades
Metrics Definitions
Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.
-
Alpha
Measures a portfolio's risk-adjusted performance against that of its benchmark
Learn More about Alpha -
Annual Standard Deviation
Measures how much the portfolio's total return varies from its mean or average.
Learn More about Annual Standard Deviation -
Annual Volatility
A statistical measure of the dispersion of returns for the portfolio.
Learn More about Annual Volatility -
Average Win
The average return (%) for trades that resulted in a positive return.
-
Average Loss
The average return (%) for trades that resulted in a negative return.
-
Beta
A measure of the volatility of the portfolio compared to the market as a whole.
Learn More about Beta -
CAGR
CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.
Learn More about CAGR -
Information Ratio
A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.
Learn More about Information Ratio -
Max Drawdown
the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.
Learn More about Max Drawdown -
Sharpe Ratio
The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.
Learn More about Sharpe Ratio -
Total Trades
The total number of trades made by this strategy.
-
Treynor Ratio
Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.
Learn More about Treynor Ratio -
Win Rate
The percentage of total trades that resulted in a positive return.
Subscribe to Quiver Premium for insider trading alerts
Be the first to see our newest insights and key updates across all datasets.
Government lobbying spending instances
Former government officials who have lobbied for VCNX
VCNX Estimated quarterly lobbying spending
VCNX Revenue by Segment or Geography
By Segment
By Geography
VCNX Income Statement
VCNX Balance Sheet
VCNX Cash Flow
U.S. Patents
New VCNX patent grants
-
Patent Title: Human anti-semaphorin 4d antibody Jun. 30, 2026
-
Patent Title: Anti-ccr8 antibodies and uses thereof Dec. 16, 2025
-
Patent Title: Use of semaphorin-4d antibodies in combination with an immune modulating therapy to inhibit tumor growth and metastasis Aug. 27, 2024
-
Patent Title: Human anti-semaphorin 4d antibody Jun. 11, 2024
-
Patent Title: Anti-cd100 antibodies and methods for using the same Jun. 11, 2024
-
Patent Title: Anti-cxcl13 antibodies and methods of using the same May. 14, 2024
-
Patent Title: Integral membrane protein display on poxvirus extracellular enveloped virions May. 07, 2024
-
Patent Title: Anti-ccr8 antibodies and uses thereof Jan. 02, 2024
-
Patent Title: Use of semaphorin-4d binding molecules for the treatment of rett syndrome Mar. 07, 2023
-
Patent Title: Treatment of cancer with a semaphorin-4d antibody in combination with an epigenetic modulating agent Feb. 07, 2023
-
Patent Title: Use of semaphorin-4d binding molecules for modulation of blood brain barrier permeability Dec. 27, 2022
-
Patent Title: Human anti-semaphorin 4d antibody Aug. 30, 2022
-
Patent Title: Anti-cd100 antibodies and methods for using the same Mar. 15, 2022
-
Patent Title: Use of semaphorin-4d inhibitory molecules with an immune modulating therapy to inhibit tumor growth and metastases Aug. 03, 2021
-
Patent Title: Integral membrane protein display on poxvirus extracellular enveloped virions Dec. 22, 2020
-
Patent Title: Polynucleotides encoding anti-cxcl13 antibodies Nov. 10, 2020
-
Patent Title: Use of semaphorin-4d binding molecules for treating neurodegenerative disorders Oct. 13, 2020
-
Patent Title: Method for selecting polynucleotides encoding antigen-specific immunoglobulin subunit May. 26, 2020
-
Patent Title: Methods for producing polynucleotide libraries in vaccinia virus/eukaryotic cells May. 05, 2020
-
Patent Title: Integral membrane protein display on poxvirus extracellular enveloped virions Mar. 03, 2020
-
Patent Title: Integral membrane protein display on poxvirus extracellular enveloped virions Feb. 04, 2020
-
Patent Title: Use of anti-semaphorin-4d antibodies in combination with an immune modulating therapy to inhibit tumor growth and metastases Jan. 07, 2020
-
Patent Title: Use of semaphorin-4d binding molecules to promote neurogenesis following stroke Dec. 03, 2019
-
Patent Title: Use of semaphorin-4d binding molecules for treating neurodegenerative disorders Aug. 20, 2019
-
Patent Title: Methods of treating multiple sclerosis using anti-cd20 antibodies May. 28, 2019
-
Patent Title: Anti-cxcl13 antibodies and methods of using the same May. 08, 2018
-
Patent Title: Methods for the treatment of b cell-mediated inflammatory diseases Feb. 13, 2018
-
Patent Title: Use of antibodies or antigen-binding fragments thereof that specifically bind semaphorin-4d to increase tumor infiltrating leukocyte frequency Nov. 28, 2017
-
Patent Title: Targeted cd1d molecules Nov. 07, 2017
-
Patent Title: Methods for increasing immunoglobulin a levels Oct. 17, 2017
-
Patent Title: Fusion proteins to facilitate selection of cells infected with specific immunoglobulin gene recombinant vaccinia virus Jul. 18, 2017
-
Patent Title: Method for selecting polynucleotides encoding antigen-specific immunoglobulin subunits Jul. 11, 2017
-
Patent Title: Anti-cd100 neutralizing antibodies and methods of using the same Jun. 13, 2017
-
Patent Title: Anti-cd100 antibodies and methods of using the same Mar. 28, 2017
-
Patent Title: Modulation of nkt cell activity with antigen-loaded cd1d molecules Mar. 28, 2017
-
Patent Title: Use of semaphorin-4d binding molecules for treating neurodegenerative disorders Mar. 21, 2017
-
Patent Title: Use of semaphorin-4d binding molecules for treatment of atherosclerosis Dec. 06, 2016
-
Patent Title: Anti-cd20 antibodies and methods of use Jul. 05, 2016
-
Patent Title: Modified glycolipids and methods of making and using the same Jun. 21, 2016
-
Patent Title: Use of semaphorin-4d binding molecules for treating neurodegenerative disorders Feb. 02, 2016
-
Patent Title: Combination of sema-4d inhibitors and immunomodulators to inhibit tumors and metastases Jan. 26, 2016
-
Patent Title: Anti-sema4d antibodies and epitopes Jul. 28, 2015
-
Patent Title: Anti-vegf antibodies and uses thereof Sep. 16, 2014
-
Patent Title: Polynucleotides encoding anti-cd100 antibodies or antigen-binding fragments thereof Aug. 26, 2014
-
Patent Title: Use of the combination of semaphorin-4d inhibitory molecules and vegf inhibitory molecules to inhibit angiogenesis Jul. 29, 2014
-
Patent Title: Anti-c35 antibody combination therapies and methods Jan. 28, 2014
-
Patent Title: Anti-cd100 neutralizing neutralizing antibodies and methods of using the same Jul. 30, 2013
-
Patent Title: Human anti-cd100 antibodies Apr. 05, 2011
-
Patent Title: Anti-il-6 monoclonal antibodies Apr. 05, 2011
-
Patent Title: Selection of human tnfα specific antibodies Oct. 05, 2010
Government Contracts
Federal grants, loans, and purchases
Government Contracts
Estimated quarterly amount awarded to VCNX from public contracts
VCNX News
Recent insights relating to VCNX
CNBC Recommendations
Recent picks made for VCNX stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in VCNX
VCNX Analyst Ratings
VCNX Stock Forecasts
...
- ... Highest Price Target
- ... Median Price Target
- ... Lowest Price Target
VCNX Analyst Forecasts
|
Analyst
|
Firm
|
Current
|
Previous
|
Date
|
|---|
Frequently Asked Questions
- Is $VCNX stock a Buy, Sell, or Hold?
- What is the price target for $VCNX stock?
* Analyst consensus is not financial advice. Please see our data disclaimers .
VCNX Top Shareholders
|
Shareholder
|
Shares Held
|
|---|
Frequently Asked Questions
- Who owns $VCNX stock?
- Who owns the most shares of $VCNX stock?
- What funds own $VCNX stock?
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
VCNX Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view VCNX Smart Score
Score Breakdown
Bull Case vs Bear Case
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
Bulls Say:
The Bulls Say summary highlights positive aspects of the stock.
Bears Say:
The Bears Say summary points out potential risks and negative aspects of the stock.
Show More
About VCNX
VACCINEX INC
VACCINEX INC (VCNX) Historical Stock Prices
VACCINEX INC (VCNX) closed at $1.00 on September 23, 2026. Over the past year its adjusted close ranged from $0.3109 to $1.50. Daily prices go back to August 9, 2018, 2,026 trading days in all.
- 1 month-4.76%
- 3 months+14.27%
- Year to date-7.02%
- 1 year+70.07%
- 3 years-96.92%
- 5 years-99.79%
- Max-99.96%
See every congressional and insider trade on the VCNX price chart
Quiver Premium charts VCNX's full daily history since 2014 with each congressional purchase and sale and every open-market insider purchase marked on the price line, with hover details for each trade.
Upgrade to Premium| Date | Open | High | Low | Close | Adj. Close | Volume |
|---|---|---|---|---|---|---|
| Sep 23, 2026 | 1.01 | 1.01 | 1.00 | 1.00 | 1.00 | 453 |
| Sep 22, 2026 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 519 |
| Sep 18, 2026 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 71 |
| Sep 17, 2026 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 265 |
| Sep 16, 2026 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 765 |
| Sep 15, 2026 | 1.05 | 1.05 | 1.00 | 1.00 | 1.00 | 2,227 |
| Sep 14, 2026 | 1.05 | 1.06 | 1.05 | 1.06 | 1.06 | 1,535 |
| Sep 11, 2026 | 0.6951 | 1.06 | 0.6900 | 1.05 | 1.05 | 42 |
| Sep 10, 2026 | 1.06 | 1.06 | 1.05 | 1.05 | 1.05 | 942 |
| Sep 9, 2026 | 1.05 | 1.06 | 1.05 | 1.05 | 1.05 | 1,518 |
| Sep 8, 2026 | 0.7502 | 1.06 | 0.7500 | 1.05 | 1.05 | 10,875 |
| Sep 4, 2026 | 0.7501 | 0.8332 | 0.7501 | 0.8320 | 0.8320 | 3 |
| Sep 3, 2026 | 1.00 | 1.00 | 0.7500 | 0.7500 | 0.7500 | 523 |
| Sep 2, 2026 | 0.7501 | 0.7501 | 0.7501 | 0.7501 | 0.7501 | 2 |
| Sep 1, 2026 | 0.8251 | 1.00 | 0.7501 | 1.00 | 1.00 | 1,038 |
| Aug 31, 2026 | 0.7550 | 1.00 | 0.7500 | 0.7500 | 0.7500 | 323 |
| Aug 28, 2026 | 1.00 | 1.00 | 0.8163 | 1.00 | 1.00 | 7,970 |
| Aug 27, 2026 | 0.7501 | 0.8943 | 0.7501 | 0.8430 | 0.8430 | 5 |
| Aug 26, 2026 | 0.7163 | 0.8840 | 0.7163 | 0.8840 | 0.8840 | 4,003 |
| Aug 25, 2026 | 0.7351 | 1.06 | 0.7164 | 0.7164 | 0.7164 | 431 |
| Aug 24, 2026 | 1.10 | 1.10 | 0.7165 | 1.05 | 1.05 | 5,075 |
| Aug 21, 2026 | 1.10 | 1.10 | 1.10 | 1.10 | 1.10 | 140 |
| Aug 20, 2026 | 0.7162 | 1.12 | 0.7162 | 0.7163 | 0.7163 | 6,920 |
| Aug 19, 2026 | 1.19 | 1.19 | 0.9725 | 1.00 | 1.00 | 11,381 |
| Aug 18, 2026 | 0.7163 | 1.25 | 0.7163 | 1.25 | 1.25 | 1,480 |
| Aug 17, 2026 | 0.8327 | 0.8414 | 0.7700 | 0.7759 | 0.7759 | 1,361 |
| Aug 14, 2026 | 0.8327 | 0.8327 | 0.8327 | 0.8327 | 0.8327 | 5 |
| Aug 13, 2026 | 0.8328 | 1.01 | 0.8327 | 0.9699 | 0.9699 | 152 |
| Aug 12, 2026 | 0.8327 | 0.9470 | 0.8327 | 0.9470 | 0.9470 | 59 |
| Aug 11, 2026 | 0.9562 | 1.29 | 0.8327 | 0.8327 | 0.8327 | 123 |
| Aug 10, 2026 | 0.8327 | 0.8327 | 0.8327 | 0.8327 | 0.8327 | 4 |
| Aug 7, 2026 | 0.9663 | 1.14 | 0.9663 | 0.9900 | 0.9900 | 773 |
| Aug 5, 2026 | 0.8276 | 1.06 | 0.8276 | 0.9563 | 0.9563 | 4 |
| Aug 4, 2026 | 0.8276 | 1.12 | 0.8276 | 0.8277 | 0.8277 | 152 |
| Aug 3, 2026 | 1.18 | 1.18 | 1.15 | 1.15 | 1.15 | 2,001 |
| Jul 31, 2026 | 0.8277 | 0.8457 | 0.8276 | 0.8276 | 0.8276 | 103 |
| Jul 30, 2026 | 0.8276 | 0.8276 | 0.8276 | 0.8276 | 0.8276 | 2 |
| Jul 29, 2026 | 0.8276 | 1.29 | 0.8276 | 1.06 | 1.06 | 104 |
| Jul 28, 2026 | 0.9663 | 0.9663 | 0.8276 | 0.8276 | 0.8276 | 10 |
| Jul 27, 2026 | 0.9663 | 0.9663 | 0.8276 | 0.8276 | 0.8276 | 2 |
| Jul 24, 2026 | 0.8276 | 1.06 | 0.8276 | 1.06 | 1.06 | 3 |
| Jul 23, 2026 | 1.10 | 1.10 | 1.10 | 1.10 | 1.10 | 2 |
| Jul 22, 2026 | 1.29 | 1.29 | 0.8277 | 0.8277 | 0.8277 | 45 |
| Jul 21, 2026 | 1.10 | 1.29 | 0.8277 | 1.29 | 1.29 | 2,616 |
| Jul 20, 2026 | 0.8700 | 1.18 | 0.8276 | 0.8276 | 0.8276 | 2,071 |
| Jul 17, 2026 | 1.12 | 1.29 | 0.8700 | 0.9960 | 0.9960 | 561 |
| Jul 16, 2026 | 1.12 | 1.21 | 1.12 | 1.20 | 1.20 | 5 |
| Jul 15, 2026 | 1.17 | 1.17 | 1.17 | 1.17 | 1.17 | 1 |
| Jul 14, 2026 | 1.12 | 1.30 | 1.12 | 1.15 | 1.15 | 658 |
| Jul 10, 2026 | 1.15 | 1.29 | 1.12 | 1.29 | 1.29 | 1,849 |
| Jul 9, 2026 | 1.20 | 1.29 | 1.11 | 1.17 | 1.17 | 1,808 |
| Jul 8, 2026 | 1.12 | 1.29 | 1.05 | 1.24 | 1.24 | 703 |
| Jul 7, 2026 | 1.00 | 1.12 | 1.00 | 1.00 | 1.00 | 144 |
| Jul 6, 2026 | 0.7702 | 1.12 | 0.7702 | 1.06 | 1.06 | 114 |
| Jul 2, 2026 | 0.7703 | 0.7703 | 0.7703 | 0.7703 | 0.7703 | 3 |
| Jul 1, 2026 | 0.7701 | 0.8751 | 0.7701 | 0.7701 | 0.7701 | 87 |
| Jun 30, 2026 | 1.00 | 1.02 | 0.7702 | 0.7702 | 0.7702 | 1,014 |
| Jun 29, 2026 | 0.7701 | 1.00 | 0.7701 | 1.00 | 1.00 | 1,112 |
| Jun 26, 2026 | 0.7701 | 0.7701 | 0.7701 | 0.7701 | 0.7701 | 7 |
| Jun 25, 2026 | 0.8296 | 0.8296 | 0.7701 | 0.7702 | 0.7702 | 162 |
| Jun 24, 2026 | 0.7850 | 0.9451 | 0.7850 | 0.8751 | 0.8751 | 54 |
| Jun 23, 2026 | 1.10 | 1.11 | 0.7850 | 0.7850 | 0.7850 | 772 |
| Jun 22, 2026 | 0.9450 | 1.12 | 0.7701 | 1.10 | 1.10 | 965 |
| Jun 18, 2026 | 1.09 | 1.13 | 1.02 | 1.11 | 1.11 | 929 |
| Jun 17, 2026 | 1.04 | 1.04 | 1.02 | 1.02 | 1.02 | 7 |
| Jun 16, 2026 | 0.7850 | 1.09 | 0.7850 | 0.9045 | 0.9045 | 1,459 |
| Jun 15, 2026 | 0.7850 | 1.05 | 0.7850 | 1.02 | 1.02 | 2,263 |
| Jun 12, 2026 | 0.8637 | 1.09 | 0.8002 | 0.9175 | 0.9175 | 1,570 |
| Jun 11, 2026 | 0.7850 | 0.7901 | 0.7701 | 0.7701 | 0.7701 | 4 |
| Jun 10, 2026 | 0.9520 | 1.09 | 0.7701 | 0.7850 | 0.7850 | 6,883 |
| Jun 9, 2026 | 0.7850 | 1.19 | 0.7700 | 1.12 | 1.12 | 6,254 |
| Jun 8, 2026 | 1.00 | 1.00 | 0.7725 | 0.9500 | 0.9500 | 4,027 |
| Jun 5, 2026 | 1.00 | 1.10 | 0.7701 | 1.10 | 1.10 | 109 |
| Jun 4, 2026 | 0.7800 | 1.02 | 0.7726 | 1.00 | 1.00 | 9,688 |
| Jun 3, 2026 | 0.7611 | 1.10 | 0.7611 | 1.10 | 1.10 | 2,191 |
| Jun 2, 2026 | 0.8000 | 0.8628 | 0.8000 | 0.8357 | 0.8357 | 1,348 |
| Jun 1, 2026 | 0.7800 | 1.00 | 0.7611 | 1.00 | 1.00 | 65 |
| May 29, 2026 | 0.8208 | 1.00 | 0.7612 | 1.00 | 1.00 | 21,991 |
| May 28, 2026 | 1.00 | 1.00 | 0.7000 | 0.9000 | 0.9000 | 11,915 |
| May 27, 2026 | 1.00 | 1.05 | 1.00 | 1.05 | 1.05 | 1,480 |
| May 26, 2026 | 1.00 | 1.10 | 1.00 | 1.00 | 1.00 | 539 |
| May 22, 2026 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 10 |
| May 21, 2026 | 1.03 | 1.03 | 1.00 | 1.02 | 1.02 | 2,012 |
| May 20, 2026 | 1.10 | 1.10 | 1.03 | 1.03 | 1.03 | 13,646 |
| May 19, 2026 | 1.06 | 1.13 | 1.06 | 1.08 | 1.08 | 36 |
| May 18, 2026 | 1.03 | 1.03 | 1.03 | 1.03 | 1.03 | 2 |
| May 15, 2026 | 1.04 | 1.10 | 1.03 | 1.03 | 1.03 | 18 |
| May 14, 2026 | 1.25 | 1.26 | 1.03 | 1.03 | 1.03 | 30 |
| May 13, 2026 | 1.16 | 1.16 | 1.01 | 1.01 | 1.01 | 4 |
| May 12, 2026 | 1.07 | 1.41 | 1.01 | 1.01 | 1.01 | 416 |
| May 11, 2026 | 1.07 | 1.07 | 1.07 | 1.07 | 1.07 | 44 |
| May 8, 2026 | 1.06 | 1.07 | 1.06 | 1.07 | 1.07 | 40 |
| May 7, 2026 | 1.06 | 1.17 | 1.06 | 1.15 | 1.15 | 14 |
| May 6, 2026 | 1.05 | 1.19 | 1.05 | 1.19 | 1.19 | 87 |
| May 5, 2026 | 1.01 | 1.50 | 1.01 | 1.50 | 1.50 | 106 |
| May 4, 2026 | 1.00 | 1.50 | 1.00 | 1.05 | 1.05 | 1,769 |
| May 1, 2026 | 0.8000 | 1.05 | 0.8000 | 1.04 | 1.04 | 1,900 |
| Apr 30, 2026 | 0.7725 | 0.8419 | 0.7725 | 0.8000 | 0.8000 | 33 |
| Apr 29, 2026 | 0.9000 | 0.9000 | 0.7000 | 0.7000 | 0.7000 | 314 |
| Apr 28, 2026 | 0.7610 | 0.9100 | 0.7610 | 0.9100 | 0.9100 | 233 |
| Apr 27, 2026 | 0.7610 | 0.9000 | 0.7610 | 0.9000 | 0.9000 | 501 |
| Apr 24, 2026 | 0.8200 | 1.05 | 0.8200 | 0.9120 | 0.9120 | 105 |
| Apr 23, 2026 | 0.8315 | 1.05 | 0.8315 | 0.9925 | 0.9925 | 1,286 |
| Apr 22, 2026 | 0.9500 | 0.9500 | 0.8200 | 0.8775 | 0.8775 | 279 |
| Apr 21, 2026 | 0.7800 | 1.05 | 0.7800 | 1.05 | 1.05 | 5,385 |
| Apr 20, 2026 | 1.00 | 1.15 | 1.00 | 1.00 | 1.00 | 4,863 |
| Apr 17, 2026 | 1.37 | 1.37 | 0.7751 | 0.7751 | 0.7751 | 13,774 |
| Apr 16, 2026 | 0.8150 | 1.28 | 0.8150 | 1.19 | 1.19 | 55 |
| Apr 15, 2026 | 1.23 | 1.50 | 1.06 | 1.16 | 1.16 | 1,920 |
| Apr 14, 2026 | 1.26 | 1.49 | 1.10 | 1.20 | 1.20 | 12,877 |
| Apr 13, 2026 | 0.7610 | 1.49 | 0.7610 | 1.28 | 1.28 | 3,347 |
| Apr 10, 2026 | 0.7100 | 1.00 | 0.7100 | 0.9805 | 0.9805 | 79 |
| Apr 9, 2026 | 1.16 | 1.18 | 0.8100 | 0.8900 | 0.8900 | 2,309 |
| Apr 8, 2026 | 1.19 | 1.28 | 0.7051 | 1.00 | 1.00 | 2,360 |
| Apr 7, 2026 | 1.17 | 1.28 | 0.7050 | 0.7288 | 0.7288 | 7,283 |
| Apr 6, 2026 | 1.17 | 1.17 | 0.6650 | 0.6650 | 0.6650 | 1,055 |
| Apr 2, 2026 | 0.9230 | 1.00 | 0.6859 | 0.6859 | 0.6859 | 604 |
| Apr 1, 2026 | 0.6551 | 1.00 | 0.6510 | 0.9100 | 0.9100 | 5,767 |
| Mar 31, 2026 | 0.6550 | 1.17 | 0.6550 | 0.7509 | 0.7509 | 4,673 |
| Mar 30, 2026 | 0.6520 | 1.00 | 0.6081 | 1.00 | 1.00 | 7,510 |
| Mar 27, 2026 | 1.19 | 1.19 | 0.6520 | 0.6520 | 0.6520 | 312 |
| Mar 26, 2026 | 1.01 | 1.19 | 0.6520 | 1.19 | 1.19 | 308 |
| Mar 25, 2026 | 0.6520 | 1.16 | 0.6520 | 0.6520 | 0.6520 | 580 |
| Mar 23, 2026 | 0.6500 | 1.20 | 0.6500 | 0.6500 | 0.6500 | 56 |
| Mar 20, 2026 | 1.30 | 1.31 | 0.5520 | 0.7105 | 0.7105 | 2,152 |
| Mar 19, 2026 | 1.00 | 1.24 | 0.6000 | 1.24 | 1.24 | 2,515 |
| Mar 18, 2026 | 1.04 | 1.04 | 1.00 | 1.00 | 1.00 | 305 |
| Mar 17, 2026 | 0.9980 | 1.18 | 0.5521 | 1.09 | 1.09 | 4,997 |
| Mar 16, 2026 | 0.6690 | 0.9980 | 0.3401 | 0.9980 | 0.9980 | 1,392 |
| Mar 13, 2026 | 0.6110 | 0.7000 | 0.3400 | 0.7000 | 0.7000 | 12,279 |
| Mar 12, 2026 | 0.5500 | 0.6616 | 0.5500 | 0.6500 | 0.6500 | 6 |
| Mar 11, 2026 | 0.6000 | 0.6722 | 0.5500 | 0.6388 | 0.6388 | 147 |
| Mar 10, 2026 | 0.5500 | 0.6048 | 0.5500 | 0.6048 | 0.6048 | 157 |
| Mar 9, 2026 | 0.7470 | 0.7470 | 0.5500 | 0.5500 | 0.5500 | 20 |
| Mar 6, 2026 | 0.6000 | 0.7975 | 0.6000 | 0.7975 | 0.7975 | 211 |
| Mar 5, 2026 | 0.6110 | 1.39 | 0.6105 | 0.8500 | 0.8500 | 1,182 |
| Mar 4, 2026 | 0.6020 | 1.50 | 0.3400 | 1.25 | 1.25 | 20,515 |
| Mar 3, 2026 | 1.10 | 1.25 | 0.7800 | 1.05 | 1.05 | 3,044 |
| Mar 2, 2026 | 1.02 | 1.15 | 1.02 | 1.15 | 1.15 | 7 |
| Feb 26, 2026 | 1.03 | 1.03 | 1.02 | 1.02 | 1.02 | 2,094 |
| Feb 25, 2026 | 1.35 | 1.35 | 1.03 | 1.03 | 1.03 | 37 |
| Feb 24, 2026 | 1.03 | 1.03 | 1.03 | 1.03 | 1.03 | 289 |
| Feb 23, 2026 | 1.03 | 1.18 | 1.03 | 1.03 | 1.03 | 170 |
| Feb 20, 2026 | 1.12 | 1.28 | 1.03 | 1.12 | 1.12 | 3,210 |
| Feb 19, 2026 | 1.02 | 1.40 | 1.02 | 1.03 | 1.03 | 64 |
| Feb 18, 2026 | 1.49 | 1.49 | 1.03 | 1.09 | 1.09 | 1,368 |
| Feb 17, 2026 | 1.25 | 1.50 | 1.05 | 1.28 | 1.28 | 4,941 |
| Feb 13, 2026 | 1.03 | 1.31 | 1.02 | 1.25 | 1.25 | 4,914 |
| Feb 12, 2026 | 1.02 | 1.25 | 1.02 | 1.22 | 1.22 | 1,006 |
| Feb 11, 2026 | 1.48 | 1.48 | 1.25 | 1.25 | 1.25 | 2,519 |
| Feb 10, 2026 | 1.19 | 1.49 | 1.05 | 1.49 | 1.49 | 5,217 |
| Feb 9, 2026 | 1.02 | 1.50 | 1.02 | 1.02 | 1.02 | 220 |
| Feb 6, 2026 | 1.20 | 1.22 | 1.03 | 1.12 | 1.12 | 269 |
| Feb 5, 2026 | 1.24 | 1.38 | 1.20 | 1.26 | 1.26 | 6,802 |
| Feb 4, 2026 | 1.20 | 1.30 | 1.20 | 1.26 | 1.26 | 1,406 |
| Feb 3, 2026 | 1.35 | 1.37 | 1.20 | 1.20 | 1.20 | 8,220 |
| Feb 2, 2026 | 1.30 | 1.35 | 1.30 | 1.35 | 1.35 | 6,003 |
| Jan 30, 2026 | 1.39 | 1.50 | 1.37 | 1.37 | 1.37 | 2,408 |
| Jan 29, 2026 | 1.30 | 1.45 | 1.30 | 1.45 | 1.45 | 66 |
| Jan 28, 2026 | 1.11 | 1.27 | 1.11 | 1.27 | 1.27 | 12 |
| Jan 27, 2026 | 1.30 | 1.30 | 1.11 | 1.30 | 1.30 | 330 |
| Jan 26, 2026 | 1.40 | 1.50 | 1.11 | 1.31 | 1.31 | 3,561 |
| Jan 23, 2026 | 1.11 | 1.50 | 1.11 | 1.39 | 1.39 | 30 |
| Jan 22, 2026 | 1.35 | 1.40 | 1.32 | 1.33 | 1.33 | 5,055 |
| Jan 21, 2026 | 1.06 | 1.38 | 1.05 | 1.32 | 1.32 | 192 |
| Jan 20, 2026 | 1.18 | 1.31 | 1.01 | 1.04 | 1.04 | 407 |
| Jan 16, 2026 | 1.10 | 1.38 | 1.10 | 1.35 | 1.35 | 3,466 |
| Jan 15, 2026 | 1.14 | 1.37 | 1.10 | 1.10 | 1.10 | 11,815 |
| Jan 14, 2026 | 1.02 | 1.13 | 1.00 | 1.00 | 1.00 | 4,380 |
| Jan 13, 2026 | 0.9000 | 1.12 | 0.9000 | 1.12 | 1.12 | 213 |
| Jan 12, 2026 | 1.00 | 1.07 | 1.00 | 1.00 | 1.00 | 4,067 |
| Jan 9, 2026 | 1.00 | 1.35 | 1.00 | 1.00 | 1.00 | 2,897 |
| Jan 8, 2026 | 1.00 | 1.34 | 0.9800 | 1.10 | 1.10 | 526 |
| Jan 7, 2026 | 1.20 | 1.25 | 0.9051 | 0.9101 | 0.9101 | 2,347 |
| Jan 6, 2026 | 1.00 | 1.35 | 1.00 | 1.30 | 1.30 | 7,634 |
| Jan 5, 2026 | 1.10 | 1.28 | 1.05 | 1.28 | 1.28 | 555 |
| Jan 2, 2026 | 1.20 | 1.37 | 1.10 | 1.10 | 1.10 | 3,437 |
| Dec 31, 2025 | 0.9000 | 1.10 | 0.9000 | 1.08 | 1.08 | 1,381 |
| Dec 30, 2025 | 1.01 | 1.11 | 1.00 | 1.05 | 1.05 | 14,405 |
| Dec 29, 2025 | 1.05 | 1.10 | 1.01 | 1.06 | 1.06 | 1,992 |
| Dec 26, 2025 | 1.18 | 1.18 | 1.00 | 1.08 | 1.08 | 5,839 |
| Dec 24, 2025 | 0.8311 | 1.18 | 0.5122 | 1.12 | 1.12 | 12,795 |
| Dec 23, 2025 | 0.7000 | 1.15 | 0.6501 | 0.9450 | 0.9450 | 9,611 |
| Dec 22, 2025 | 0.7900 | 0.7900 | 0.6137 | 0.7000 | 0.7000 | 16,847 |
| Dec 19, 2025 | 0.7000 | 0.9200 | 0.5134 | 0.7900 | 0.7900 | 28,773 |
| Dec 18, 2025 | 0.5615 | 0.7000 | 0.5001 | 0.5001 | 0.5001 | 13,983 |
| Dec 17, 2025 | 0.5981 | 0.6257 | 0.5981 | 0.6257 | 0.6257 | 129 |
| Dec 16, 2025 | 0.5981 | 0.6211 | 0.5981 | 0.5981 | 0.5981 | 1,161 |
| Dec 15, 2025 | 0.5000 | 0.5737 | 0.5000 | 0.5700 | 0.5700 | 167 |
| Dec 12, 2025 | 0.6899 | 0.6899 | 0.5001 | 0.5001 | 0.5001 | 229 |
| Dec 11, 2025 | 0.6700 | 0.7000 | 0.5000 | 0.5000 | 0.5000 | 511 |
| Dec 10, 2025 | 0.3394 | 0.6899 | 0.3394 | 0.6899 | 0.6899 | 205 |
| Dec 9, 2025 | 0.3394 | 0.6703 | 0.3394 | 0.6700 | 0.6700 | 310 |
| Dec 8, 2025 | 0.4000 | 0.6999 | 0.3394 | 0.5000 | 0.5000 | 766 |
| Dec 5, 2025 | 0.5000 | 0.6995 | 0.5000 | 0.5200 | 0.5200 | 168 |
| Dec 4, 2025 | 0.6996 | 0.6996 | 0.5000 | 0.5598 | 0.5598 | 564 |
| Dec 3, 2025 | 0.3393 | 0.6898 | 0.3393 | 0.5000 | 0.5000 | 1,252 |
| Dec 2, 2025 | 0.3684 | 0.6999 | 0.3369 | 0.4200 | 0.4200 | 2,500 |
| Dec 1, 2025 | 0.3201 | 0.6999 | 0.3201 | 0.6998 | 0.6998 | 3,824 |
| Nov 28, 2025 | 0.6988 | 0.6999 | 0.3100 | 0.3656 | 0.3656 | 1,401 |
| Nov 26, 2025 | 0.6844 | 0.7000 | 0.3000 | 0.6680 | 0.6680 | 439 |
| Nov 25, 2025 | 0.3599 | 0.6990 | 0.3010 | 0.6990 | 0.6990 | 307 |
| Nov 24, 2025 | 0.3011 | 0.6790 | 0.3010 | 0.6790 | 0.6790 | 118 |
| Nov 21, 2025 | 0.3000 | 0.7000 | 0.3000 | 0.7000 | 0.7000 | 116 |
| Nov 20, 2025 | 0.3824 | 0.6990 | 0.3824 | 0.6990 | 0.6990 | 729 |
| Nov 19, 2025 | 0.6978 | 0.6978 | 0.3824 | 0.6890 | 0.6890 | 1,693 |
| Nov 18, 2025 | 0.4024 | 0.4024 | 0.3824 | 0.3824 | 0.3824 | 20 |
| Nov 17, 2025 | 0.4800 | 0.7000 | 0.3813 | 0.4291 | 0.4291 | 1,603 |
| Nov 14, 2025 | 0.3700 | 0.6985 | 0.3700 | 0.6985 | 0.6985 | 1,171 |
| Nov 13, 2025 | 0.6999 | 0.6999 | 0.3500 | 0.4800 | 0.4800 | 1,417 |
| Nov 12, 2025 | 0.4500 | 0.6594 | 0.4300 | 0.4516 | 0.4516 | 367 |
| Nov 11, 2025 | 0.3757 | 0.5000 | 0.3757 | 0.4800 | 0.4800 | 15,124 |
| Nov 10, 2025 | 0.3500 | 0.4550 | 0.3500 | 0.3944 | 0.3944 | 1,127 |
| Nov 7, 2025 | 0.3600 | 0.7286 | 0.3600 | 0.6100 | 0.6100 | 3,207 |
| Nov 6, 2025 | 0.2488 | 0.7867 | 0.2488 | 0.7087 | 0.7087 | 1,364 |
| Nov 5, 2025 | 0.1001 | 0.8789 | 0.1001 | 0.7216 | 0.7216 | 669 |
| Nov 4, 2025 | 0.3210 | 0.6310 | 0.3210 | 0.6310 | 0.6310 | 18 |
| Nov 3, 2025 | 0.2501 | 0.5500 | 0.2501 | 0.3109 | 0.3109 | 9,654 |
| Oct 31, 2025 | 0.5798 | 0.6311 | 0.5511 | 0.6311 | 0.6311 | 2,739 |
| Oct 30, 2025 | 0.7199 | 0.7199 | 0.5500 | 0.5933 | 0.5933 | 1,683 |
| Oct 29, 2025 | 0.5002 | 0.6842 | 0.5002 | 0.6842 | 0.6842 | 401 |
| Oct 28, 2025 | 0.5001 | 0.7350 | 0.5001 | 0.7200 | 0.7200 | 182 |
| Oct 27, 2025 | 0.7000 | 0.7447 | 0.4951 | 0.7200 | 0.7200 | 5,568 |
| Oct 24, 2025 | 0.7000 | 0.8787 | 0.7000 | 0.8787 | 0.8787 | 1,777 |
| Oct 23, 2025 | 0.9000 | 0.9200 | 0.7000 | 0.7200 | 0.7200 | 2,722 |
| Oct 22, 2025 | 0.7000 | 0.9000 | 0.7000 | 0.8675 | 0.8675 | 4,154 |
| Oct 21, 2025 | 0.9199 | 0.9199 | 0.7100 | 0.7611 | 0.7611 | 657 |
| Oct 20, 2025 | 0.5500 | 0.9697 | 0.5500 | 0.9198 | 0.9198 | 1,951 |
| Oct 17, 2025 | 0.5500 | 0.9497 | 0.5500 | 0.5500 | 0.5500 | 61 |
| Oct 16, 2025 | 0.4501 | 0.5500 | 0.4501 | 0.5500 | 0.5500 | 14 |
| Oct 15, 2025 | 0.4751 | 0.9697 | 0.4751 | 0.9697 | 0.9697 | 905 |
| Oct 14, 2025 | 0.5501 | 0.5836 | 0.5501 | 0.5836 | 0.5836 | 5 |
| Oct 13, 2025 | 0.5244 | 0.9697 | 0.5242 | 0.5242 | 0.5242 | 503 |
| Oct 10, 2025 | 0.5243 | 0.5244 | 0.5243 | 0.5244 | 0.5244 | 5 |
| Oct 9, 2025 | 0.5243 | 0.5443 | 0.5243 | 0.5443 | 0.5443 | 17 |
| Oct 8, 2025 | 0.5500 | 0.5500 | 0.5243 | 0.5243 | 0.5243 | 60 |
| Oct 7, 2025 | 0.5001 | 1.10 | 0.5000 | 0.5581 | 0.5581 | 6,355 |
| Oct 6, 2025 | 0.5700 | 0.5901 | 0.5001 | 0.5002 | 0.5002 | 62 |
| Oct 3, 2025 | 0.5116 | 0.5999 | 0.5000 | 0.5000 | 0.5000 | 36 |
| Oct 2, 2025 | 0.5700 | 1.13 | 0.5469 | 0.5587 | 0.5587 | 3,748 |
| Oct 1, 2025 | 0.5600 | 0.6056 | 0.5600 | 0.6056 | 0.6056 | 72 |
| Sep 30, 2025 | 1.13 | 1.13 | 0.5500 | 0.5500 | 0.5500 | 57 |
| Sep 29, 2025 | 0.7574 | 1.13 | 0.5790 | 0.6200 | 0.6200 | 2,487 |
| Sep 26, 2025 | 0.5037 | 1.06 | 0.5037 | 0.8800 | 0.8800 | 9,216 |
| Sep 25, 2025 | 0.4501 | 0.6999 | 0.4501 | 0.5501 | 0.5501 | 222 |
| Sep 24, 2025 | 0.5550 | 0.6450 | 0.5400 | 0.5400 | 0.5400 | 646 |
| Sep 23, 2025 | 0.5037 | 0.6720 | 0.5037 | 0.5880 | 0.5880 | 1,360 |
Open, high, low and close are the prices as traded. Adjusted close accounts for splits and dividends, and is what the chart and returns use. Where a company changed its ticker, its history under the old symbol is included.
Need daily prices for every ticker, in code?
The Quiver API serves daily prices back to 2014 alongside congressional trades, insider trades, 13F holdings and lobbying, all under one key and inside Claude or ChatGPT through our MCP server.
Explore the Quiver API
VACCINEX INC Executive Compensation
We estimate that -- received a compensation of -- in --, making them the highest paid executive at VCNX, per a recent SEC DEF 14A filing.
|
Name
|
Role
|
Salary
|
Bonus
|
Stock/Option Awards
|
Total Compensation
|
|---|